---
category: news
title: "Sanofi bets big on AI again, paying $100M to start drug R&D pact with Exscientia"
excerpt: "Sanofiâ€™s new alliance with artificial intelligence biotech Exscientia spans up to 15 small molecule drugs in cancer and immunology. If drugs from the partnership reach the market, Exscientia could earn as much as $5."
publishedDateTime: 2022-01-07T16:15:00Z
originalUrl: "https://medcitynews.com/2022/01/sanofi-bets-big-on-ai-again-paying-100m-to-start-drug-rd-pact-with-exscientia/"
webUrl: "https://medcitynews.com/2022/01/sanofi-bets-big-on-ai-again-paying-100m-to-start-drug-rd-pact-with-exscientia/"
type: article
quality: 32
heat: -1
published: false

provider:
  name: MedCity News
  domain: medcitynews.com

topics:
  - AI

images:
  - url: "https://medcitynews.com/uploads/2021/04/GettyImages-1230836886.jpg"
    width: 1024
    height: 683
    isCached: true

related:
  - title: "Healthcare group Sanofi forms research deal with the company Exscientia"
    excerpt: "French healthcare company Sanofi, which has been under pressure to revive its drug pipeline after some setbacks in the COVID-19 vaccine race, announced on Friday a research deal with the company Exscientia to develop new medicines."
    publishedDateTime: 2022-01-07T06:44:00Z
    webUrl: "https://www.channelnewsasia.com/business/healthcare-group-sanofi-forms-research-deal-company-exscientia-2420706"
    type: article
    provider:
      name: Channel NewsAsia Singapore
      domain: channelnewsasia.com
    quality: 39
    images:
      - url: "https://onecms-res.cloudinary.com/image/upload/s--VLEtxmPC--/fl_relative%2Cg_south_east%2Cl_one-cms:core:watermark:reuters%2Cw_0.1/f_auto%2Cq_auto/c_fill%2Cg_auto%2Ch_676%2Cw_1200/v1/one-cms/core/2022-01-07t064223z_2_lynxmpei06064_rtroptp_3_sanofi-results.jpg?itok=gm1J4PRI"
        width: 1200
        height: 676
        isCached: true

secured: "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;VASRl5iZyg1eHROTo7lOXQ=="
---

